Home is where the heart is, as the old saying goes. But in the Danish suburb of Bagsværd, some 12 kilometers northwest of Copenhagen, Denmark’s biggest pharmaceutical company Novo Nordisk is showing signs that it holds a different view.

The soon-to-be centenarian pharmaceutical firm has completed large, billion-dollar acquisitions in a hunt for more growth, and has entered partnerships and strategic collaboration with external parties.